Bosentan in Systemic Sclerosis

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Systemic SclerosisDigital Ulcers
Interventions
DRUG

Bosentan

2 tablets of 62.5 mg a day from baseline to week 4, then 2 tablets of 125 mg per day to week 12.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY

NCT01395732 - Bosentan in Systemic Sclerosis | Biotech Hunter | Biotech Hunter